Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$60.02−1.70 (-2.75%)
Close on Nov 16, 2026Market cap $2.06BP/E 40.8Yield –
Ingevity cash
Cash and short-term investments held at the end of each period.
Ingevity's cash was $97.40M at Jun 30, 2026. For fiscal 2025 it was $78.10M, up 14.9% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $280.70M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.10M | +14.9% |
| FY2024 | Dec 31, 2024 | $68.00M | -29.1% |
| FY2023 | Dec 31, 2023 | $95.90M | +13.8% |
| FY2022 | Dec 31, 2022 | $84.30M | -70.0% |
| FY2021 | Dec 31, 2021 | $280.70M | +7.6% |
| FY2020 | Dec 31, 2020 | $260.80M | +303.7% |
| FY2019 | Dec 31, 2019 | $64.60M | -17.0% |
| FY2018 | Dec 31, 2018 | $77.80M | -11.5% |
| FY2017 | Dec 31, 2017 | $87.90M | +188.2% |
| FY2016 | Dec 31, 2016 | $30.50M | -4.7% |
| FY2015 | Dec 31, 2015 | $32.00M | +60.8% |
| FY2014 | Dec 31, 2014 | $19.90M | +73.0% |
| FY2013 | Dec 31, 2013 | $11.50M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $97.40M | +26.7% |
| Q1 FY2026 | Mar 31, 2026 | $95.40M | +33.4% |
| Q4 FY2025 | Dec 31, 2025 | $78.10M | +14.9% |
| Q3 FY2025 | Sep 30, 2025 | $83.40M | -38.5% |
| Q2 FY2025 | Jun 30, 2025 | $76.90M | -28.4% |
| Q1 FY2025 | Mar 31, 2025 | $71.50M | -19.2% |
| Q4 FY2024 | Dec 31, 2024 | $68.00M | -29.1% |
| Q3 FY2024 | Sep 30, 2024 | $135.50M | +60.4% |
| Q2 FY2024 | Jun 30, 2024 | $107.40M | +57.9% |
| Q1 FY2024 | Mar 31, 2024 | $88.50M | +13.6% |
| Q4 FY2023 | Dec 31, 2023 | $95.90M | +13.8% |
| Q3 FY2023 | Sep 30, 2023 | $84.50M | +16.9% |
| Q2 FY2023 | Jun 30, 2023 | $68.00M | -48.2% |
| Q1 FY2023 | Mar 31, 2023 | $77.90M | -65.0% |
| Q4 FY2022 | Dec 31, 2022 | $84.30M | -70.0% |
| Q3 FY2022 | Sep 30, 2022 | $72.30M | -73.2% |
| Q2 FY2022 | Jun 30, 2022 | $131.30M | -43.7% |
| Q1 FY2022 | Mar 31, 2022 | $222.60M | -6.4% |
| Q4 FY2021 | Dec 31, 2021 | $280.70M | +7.6% |
| Q3 FY2021 | Sep 30, 2021 | $269.40M | +35.9% |
| Q2 FY2021 | Jun 30, 2021 | $233.30M | +31.4% |
| Q1 FY2021 | Mar 31, 2021 | $237.80M | -21.4% |
| Q4 FY2020 | Dec 31, 2020 | $260.80M | +303.7% |
| Q3 FY2020 | Sep 30, 2020 | $198.20M | +162.2% |
| Q2 FY2020 | Jun 30, 2020 | $177.60M | +233.2% |
| Q1 FY2020 | Mar 31, 2020 | $302.70M | +666.3% |
| Q4 FY2019 | Dec 31, 2019 | $64.60M | -17.0% |
| Q3 FY2019 | Sep 30, 2019 | $75.60M | +31.5% |
| Q2 FY2019 | Jun 30, 2019 | $53.30M | -35.8% |
| Q1 FY2019 | Mar 31, 2019 | $39.50M | -52.4% |
| Q4 FY2018 | Dec 31, 2018 | $77.80M | -11.5% |
| Q3 FY2018 | Sep 30, 2018 | $57.50M | -18.1% |
| Q2 FY2018 | Jun 30, 2018 | $83.00M | +104.4% |
| Q1 FY2018 | Mar 31, 2018 | $83.00M | +179.5% |
| Q4 FY2017 | Dec 31, 2017 | $87.90M | +188.2% |
| Q3 FY2017 | Sep 30, 2017 | $70.20M | +159.0% |
| Q2 FY2017 | Jun 30, 2017 | $40.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $29.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $30.50M | – |
| Q3 FY2016 | Sep 30, 2016 | $27.10M | – |
See a number that looks wrong?